연구: Tesamorelin

FDA-approved GHRH analog for HIV-associated lipodystrophy

Tesamorelin
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy
Drugs 2011 300 Review
Tesamorelin is the first and only approved treatment for reducing excess abdominal fat in HIV lipodystrophy, significantly reducing visceral adipose tissue over 26 weeks.